These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8334339)

  • 1. [Effects of baoshen pill in treating chronic renal failure with long-term hemodialysis].
    Ji SM; Li LS; Ji DX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Feb; 13(2):71-3, 67. PubMed ID: 8334339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of rheum and captopril on preventing progression of chronic renal failure.
    Zhang JH; Li LS; Zhang M
    Chin Med J (Engl); 1990 Oct; 103(10):788-93. PubMed ID: 2125252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and experimental studies of rheum on preventing progression of chronic renal failure].
    Li LS; Liu ZH
    Zhong Xi Yi Jie He Za Zhi; 1991 Jul; 11(7):392-6, 387. PubMed ID: 1914031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in HDL-cholesterol, subfractions HDL2 and HDL3 and apo-A, apo-A1 and apo-B lipoproteins in patients with chronic renal failure subjected to maintenance hemodialysis].
    Scarazatti E; Garavaglia G
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):15-21. PubMed ID: 3977994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients.
    Rahimi-Ardabili B; Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Naghavi-Behzad M; Ghorashi S; Nezami N
    Ren Fail; 2012; 34(9):1123-8. PubMed ID: 22950600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on niaodujing in treating chronic renal failure].
    Wang YJ; Xu L; Cheng XX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Nov; 16(11):649-51. PubMed ID: 9772612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.
    Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
    Miner Electrolyte Metab; 1992; 18(2-5):199-202. PubMed ID: 1465058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress on research of mechanism of Rheum palmatum in delaying the chronic renal failure].
    Huang CL; Li C; Deng YB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Aug; 15(8):506-8. PubMed ID: 8580699
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of Chinese herbal enema therapy combined basic treatment on BUN, SCr, UA, and IS in chronic renal failure patients].
    Zou C; Wu YC; Lin QZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1192-5. PubMed ID: 23185756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum apolipoproteins A1, B and Apo A1/Apo B index in children with advanced chronic renal failure and on dialysis].
    Puziewicz-Zmonarska A; Zwolińska D; Makulska I; Zmonarski SC
    Pol Merkur Lekarski; 2003 Apr; 14(82):299-303. PubMed ID: 12868188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
    Takegoshi T; Kitoh C; Yamazaki Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheum officinale: a new lead in preventing progression of chronic renal failure.
    Li L
    Chin Med J (Engl); 1996 Jan; 109(1):35-7. PubMed ID: 8758359
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
    Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased lipoprotein-remnant formation in chronic renal failure.
    Nestel PJ; Fidge NH; Tan MH
    N Engl J Med; 1982 Aug; 307(6):329-33. PubMed ID: 7088097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observation of therapeutic effect in 50 cases of chronic renal failure treated with rhubarb and adjuvant drugs.
    Kang Z; Bi Z; Ji W; Zhao C; Xie Y
    J Tradit Chin Med; 1993 Dec; 13(4):249-52. PubMed ID: 8139271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.